Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Valpiani D"'
Autor:
Burisch, J., Weimers, P., Pedersen, N., Cukovic-Cavka, S., Vucelic, B., Kaimakliotis, I., Duricova, D., Bortlik, M., Shonová, O., Vind, I., Avnstrøm, S., Thorsgaard, N., Krabbe, S., Andersen, V., Dahlerup, J.F., Kjeldsen, J., Salupere, R., Olsen, J., Nielsen, K.R., Manninen, P., Collin, P., Katsanos, K.H., Tsianos, E.V., Ladefoged, K., Lakatos, L., Ragnarsson, G., Björnsson, E., Bailey, Y., O'Morain, C., Schwartz, D., Odes, S., Valpiani, D., Boni, M.C., Jonaitis, L., Kupcinskas, L., Turcan, S., Barros, L., Magro, F., Lazar, D., Goldis, A., Nikulina, I., Belousova, E., Fernandez, A., Sanroman, L., Almer, S., Zhulina, Y., Halfvarson, J., Arebi, N., Diggory, T., Sebastian, S., Lakatos, P.L., Langholz, E., Munkholm, P.
Publikováno v:
In Journal of Crohn's and Colitis 1 September 2014 8(9):1030-1042
Autor:
Riegler, G., Caserta, L., Castiglione, F., Esposito, I., Valpiani, D., Annese, V., Zoli, G., Gionchetti, P., Viscido, A., Sturniolo, G.C., Rispo, A., De Filippo, F.R., de Leone, A., Carratu, R.
Publikováno v:
In Digestive and Liver Disease 2006 38(1):18-23
Publikováno v:
In Digestive and Liver Disease 2004 36(12):847-851
Autor:
Burisch, J., Andersen, V., Cukovic-Cavka, S., Lakatos, P. L., D Inca, R., Magro, F., Arebi, N., Kievit, L., Kaimakliotis, I., Valpiani, D., Katsanos, K. H., Vegh, Z., Dahlerup, J. F., Fumery, M., Pedersen, N., Halfvarson, J., Belousova, E., Nielsen, K. R., Turcan, S., Ellul, P., Kupcinskas, L., Oksanen, P., Duricova, D., Giannotta, M., Goldis, A., Vicent Hernandez, Salupere, R., Odes, S., Langholz, E., Munkholm, P.
Publikováno v:
Journal of Crohn's and Colitis : Abstracts of the 12th Congress of ECCO "Inflammatory Bowel Diseases" : February 15-18, 2017, Barcelona, Spain / European Crohn’s and Colitis Organisation, Oxford : Oxford University Press, 2018, vol. 12, suppl. 1, February, p. S042-S043, no. DOP019
Web of Science
Web of Science
Background: Immunomodulators have both been shown to improve the disease course in IBD patients: however, the literature remains inconsistent. The aim of the study was to investigate the impact of treatment with immunomodulators and biological therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e738b2838a583320c05ac529d2c803a8
https://library.lsmuni.lt/LSMU:ELABAPDB26161437&prefLang=en_US
https://library.lsmuni.lt/LSMU:ELABAPDB26161437&prefLang=en_US
Clinical features in familial cases of Crohn’s disease and ulcerative colitis in Italy: a GISC study
Autor:
Annese, V *, Andreoli, A, Astegiano, M, Campieri, M, Caprilli, R, Cucchiara, S, D’Incà, R, Giaccari, S, Iaquinto, G, Lombardi, G, Napolitano, G, Pera, A, Riegler, G, Valpiani, D, Andriulli, A
Publikováno v:
In The American Journal of Gastroenterology 2001 96(10):2939-2945
Autor:
Bortoli A, Pedersen N, Duricova D, D'Inca R, Gionchetti P, Panelli MR, Ardizzone S, Sanroman AL, Gisbert JP, Arena I, Marrollo M, Valpiani D, Corbellini A, Segato S, Castiglione F, Munkholm P, European Crohn Colitis Organisation Study Group of Epidemiologic Committee, RIEGLER, Gabriele
Publikováno v:
Alimentary pharmacologytherapeutics. 34(7)
BACKGROUND: Inflammatory bowel disease (IBD) frequently affects women during their reproductive years. Pregnancy outcome in women with IBD is well described, particularly in retrospective studies. AIM: To evaluate the pregnancy outcome in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2c281fa4ef2c0dcbbb0b4ff133166787
https://pubmed.ncbi.nlm.nih.gov/21815900
https://pubmed.ncbi.nlm.nih.gov/21815900
Autor:
Bortoli A, Daperno M, Kohn A, Politi P, Marconi S, Monterubbianesi R, Castiglione F, Corbellini A, Merli M, Casella G, D'Inca R, Orlando A, Bossa F, Doldo P, Lecis P, Valpiani D, Danese S, Comberlato M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::dc52bd3c50138bed32864c4922ad4bbf
Autor:
Ferraro, Pietro Manuel, D'Ovidio, V, Bresci, G, Astegiano, M, Principi, B, D'Inca', R, Testa, R, Valpiani, D, Guidi, Luisa, Armuzzi, Alessandro, Costa, F, Aratari, A, Vecchi, M, De Franchis, R, Di Leo, V, Ricci, C, Riegler, G, Colombo, E, Repaci, G, Lecis, P, Silla, M, Passalacqua, S.
Publikováno v:
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 29
We analyzed predictors of clinical response after a cycle of granulocytemonocyte apheresis in 173 patients with ulcerative colitis. Hemoglobin levels independently predicted good clinical outcome.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::94cbfa4fca003a749f8a79624e2340fa
https://pubmed.ncbi.nlm.nih.gov/22388848
https://pubmed.ncbi.nlm.nih.gov/22388848
Autor:
Mikhailova TL, Sishkova E, Poniewierka E, Zhidkov KP, Bakulin IG, Kupcinskas L, Lesniakowski K, Grinevich VB, Malecka Panas E, Ardizzone S, Valpiani D, Koch M, Denapiene G, Vago G, Fociani P, Zerbi P, Ceracchi M, Camerini R, Gasbarrini G., D'ARIENZO, AGESILAO
Publikováno v:
Alimentary pharmacologytherapeutics. 34(9)
Ulcerative colitis (UC) is characterised by impaired fatty-acid oxidation; l-carnitine has a key role in fatty-acid metabolism and short-chain fatty acids such as butyrate and propionate are important energy source for intestinal epithelial cells.To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d34b4c949303122d847d132ebed3ea74
https://pubmed.ncbi.nlm.nih.gov/22248423
https://pubmed.ncbi.nlm.nih.gov/22248423
Autor:
Gionchetti, P., D'Arienzo, A., Rizzello, F., Manguso, F., Maieron, R., Lecis, P. E., Valpiani, D., Iaquinto, G., Annese, V., Balzano, A., Varoli, G., Campieri, M., Bennato, R., Zilli, M., Biedo, F. C., Germana, B., Bove, A., Lombardi, G., Pasquale, L., Andriulli, A., D'Albasio, G., Bagnoli, S., Adamo, S., Desideri, S., Benedetti, G., Sablich, R., Riegler, G., Caserta, L., Belletta, M., Benedetti, A., Ridolfi, F., Blasi, A., Inserra, G., Prada, A., Ferrau, O., Turiano, S., Loriga, P., Muscas, A., Murgia, R., Colombo, E., Canevelli, E., Menardo, G., Dagnino, F., Monica, F., Giordano, M., Torelli, I., Cuoco, D. L., Villa, E., Rigo, G., Bertani, A., Cremonini, C., Minoli, G., Meucci, G., Cattoni, M.
Therapy for active ulcerative colitis (UC) usually involves rectal formulations of corticosteroids (CS), which are characterized by the risk of systemic steroid-related adverse effects.To compare the efficacy and safety of the topically acting CS bec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e69b7b282d7df7112f8ce13a49e90d
http://hdl.handle.net/11588/491872
http://hdl.handle.net/11588/491872